View all IQVIA events
SOLUTIONS
-
Life Sciences Solutions
-
Healthcare Solutions
-
Medical Device and Diagnostic
-
U.S. Government
Life Sciences Solutions
Bringing together unparalleled healthcare data, advanced analytics, innovative technologies, and healthcare expertise to create intelligent connections that speed the development and commercialization of innovative medicines to improve patient lives.
Learn MoreLife Sciences Solutions
Healthcare Solutions
Accelerate digital innovation to enable smarter decisions that reduce cost, modernize patient and consumer engagement, and improve health outcomes.
Learn MoreHealthcare Solutions
Medical Device and Diagnostic Solutions
Your world is unique – and quite different from pharma. In the U.S., decision-making has shifted from individual physicians to integrated networks--GPOs, IDNs and payers. These groups have heightened the focus on proving your solution’s value, demanding outcomes analyses and putting pressure on pricing.
Learn MoreMedical Device and Diagnostic Solutions
U.S. Government Solutions
For government agencies and organizations at every level—from federal or national to regional and local—Big Data can have a huge impact on public health.
Learn MoreU.S. Government Solutions
U.S. PROGRESS POINT
A curation of IQVIA's best thinking on topics and trends driving change, disruption, and progress in the United States healthcare market.
LEARN MOREU.S. BLOGS
Get the latest insights on our life sciences, healthcare, and medical technology solutions in the United States. Follow our blog today!
LEARN MORE
In this webinar, we'll take IQVIA's new National Medical and Treatment Audit (NMTA) and Diagnosis Allocation (DA) tools for a spin. IQVIA's newest data solution, NMTA and DA, enables researchers to explore variations by patient geography, demographics, physician specialty, method of payment, and diagnosis across time on responses to questions such as:
- What percentage of upper respiratory infection diagnoses result in an anti-infective prescription?
- What are the most common medications dispensed for Type 1 diabetes in children?
- What is the most common indication for the prescription of opioids to patients during the first, second, or third diagnosed visit?
- Which pain diagnoses are commonly associated with prescriptions for specific products?
- How do prescribing patterns differ in the pre- and post-COVID eras?
Speakers
Melanie Wasserman, PhD, PMP
Principal, IQVIA Government Solutions, IQVIA
Silvia Valkova
Principal, IQVIA Government Solutions, IQVIA
Maria Elisabeth Murray, PhD
Engagement Manager, IQVIA Government Solutions, IQVIA
Sarah Sharkey, MPH
Senior Consultant, IQVIA Government Solutions, IQVIA